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phrenia who presented an exceptional clinical response to Clozapine. iPSC lines were established with a non-in-
tegrating reprogramming system based on Sendai virus. A footprint-free hiPSC linewas characterized to conﬁrm
the expression of the main endogenous pluripotency markers and have a regular karyotype. Pluripotency was
conﬁrmed by differentiation into cells belonging to the three germ layers. This hiPSC line represents a valuable
tool to study the molecular, biochemical and electrophysiological properties of mature neuronal populations
belonging to Clozapine responder patients with a severe form of Schizophrenia.
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Blood sample was collected by a 40-year old male patient with a di-
agnosis of treatment-refractory Schizophrenia at the Department of
Mental Health of the San Paolo Hospital, Milan (Italy). The diagnosis of
Schizophrenia was conﬁrmed by the assessment of two independent
psychiatrists with the Structured Clinical Interview for DSM-IV Axis I
Disorders (SCID-I).
According to speciﬁc criteria (Caspi et al., 2004), the treatment-resis-
tance to conventional antipsychotics justiﬁed the introduction of Cloza-
pine which resulted in an extraordinary clinical response. Indeed, the
patient underwent multiple hospitalizations for approximately a de-
cade after onset of symptoms associated with a marked psychosocial
impairment. After stabilization on Clozapine, the patient was never
again hospitalized and satisﬁed speciﬁc criteria for full recovery from
Schizophrenia (Jaaskelainen et al., 2013).
To generate the SCZ#4-9 iPSC line, an integration-free gene delivery
method (CytoTune™-iPS 2.0 Sendai Reprogramming Kit; Thermo Fi-
scher Scientiﬁc) of the four Yamanaka reprogramming factors OCT4,
SOX2, KLF4, and C-MYC (Takahashi et al., 2007) based on Sendai viralmmons.org/licenses/by-nc-nd/4.0/).
Fig. 1. Characterization of SCZ#4-9 iPSC line. A: Representative image of a SCZ#4-9 hiPSC colony (5×) and its karyogram showing a normal diploid 46, XY karyotype with no noticeable
cytogenetic aberrations. Immunocytochemical analysis presenting the expression of the pluripotency markers OCT4, TRA-1-60, SOX2 (20×). B: RT-PCR presenting the expression of
the pluripotency-associated transcripts in SCZ#4-9 iPSCs cultures and in another hiPSC clone (SCZ#4-13) derived from the same patient at passages 0 and 10. Absence of Sendai virus
genome conservation is shown in passage 10 cultures. A commercial hiPSC line was used as positive control for pluripotency-associated transcripts. C: Western blot analysis showing
expression levels of pluripotency-associated markers (NANOG, SOX2, TRA1-60, OCT4) in SCZ#4-9 iPSCs and in nine other iPSC clones obtained from the same patient.
631M. Marcatili et al. / Stem Cell Research 17 (2016) 630–633particles (Fusaki et al., 2009; Yang et al., 2008-2012)was used. iPSC-like
colonies appeared after 10–12 days and were picked one week later
(Fig. 1A). One of the selected clones gave rise to the established
SCZ#4-9 iPSC line with a characteristic iPSC-like morphology (Fig. 1A)
and speciﬁc immunoreactivity for OCT4, SOX2 and TRA1-60
pluripotency-associated markers (Fig. 1A). PCR (Fig. 1B) and Western
Blot (Fig. 1C) analyses conﬁrmed the expression of pluripotency tran-
scripts. SCZ#4-9 iPSC line displayed a normal diploid 46, XY karyotype,
without noticeable abnormalities (Fig. 1B). The expression of Sendai
virus genome in cultures at passage 0 and passage 10 was analyzed by
PCR and the loss of the viral genome was conﬁrmed in passage 10
SCZ#4-9 iPSCs (Fig. 1B).
Embryoid body assay was performed to assess the pluripotent com-
petence SCZ#4-9 iPSC line. Cells were cultured for one week in EB sus-
pension and for additional 7 days in adhesion to promote the in vitro
maturation towards the three germ layer derivatives (Carpenter et al.,
2003). EBs cultures at 14 days displayed the presence of differentiated
cells immunoreactive for ectodermal (β3-Tubulin), mesodermal (α-
SMA) and endodermal (AFP) markers (Fig. 2A). The differentiation
competency of SCZ#4-9 iPSCs was comparable to that observed for a
commercial hiPSC line, as shown by the similar expression levels of
transcripts for FGF5 (ectoderm marker), Nestin (neuro-ectodermFig. 2. In vitro differentiation SCZ#4-9 iPSC line. A: Embryoid Bodies obtained after 4 days of su
Tubulin), mesodermal (α-SMA) and endodermal (AFP) germ layer markers (20×). B: qRT-P
(ectoderm), Nestin and ß3-Tubulin (neuro-ectoderm), T-Brachyury (mesoderm) and AF
differentiated reference commercial hiPSCs.marker), T-Brachyury (mesoderm marker), SOX-17 (endoderm mark-
er) assessed by qRT-PCR (Fig. 2B).
Materials and methods
PBMCs collection and freezing
Peripheral Blood Mononuclear Cells (PBMCs) from patients were
isolated in BD Vacutainer CPT Cell Preparation tubes with sodium
citrate, after 30 min centrifugation (1800 ×g at room temperature).
PBMCswere collected in PBS for a total volume of 35ml and centrifuged
at 300 ×g for 15 min RT and resuspended in fetal bovine serum (FBS)
with 10% DMSO. 2 × 106 cells were aliquoted and frozen.
PBMCs thawing and reprogramming with Sendai virus particles
PBMCs were thawed at 37 °C and centrifuged at 200 ×g for 10min in
expansion medium (EM) made of StemPro-34 Serum Free Medium
(SFM, Thermo Fisher Scientiﬁc) BasalMedium, StemPro-34Nutrient Sup-
plement, 200 mM GlutaMAX, 1% Penicillin/Streptomycin, 100 ng/ml
StemCell Factor (SCF, Prepotech), 100 ng/ml FLT-3 (Thermo Fisher Scien-
tiﬁc), 20 ng/ml Interleukin-6 (IL-6) (Thermo Fisher Scientiﬁc), 20 ng/mlspension culture (5×). D14 cultures exhibit cells immuonoreactive for ectodermal (β3-
CR presenting comparable expression levels of transcripts for the 3 germ-layers, FGF5
P (endoderm) between 14 days differentiated SCZ#4-9 iPSCs, SCZ#4-13 iPSCs and
Table 1
List of primers sequences, amplicons size and number of PCR cycles.
Gene Primer sequenze Amplicon size Cycles (PCR)
BETA ACTIN F: GACAGGATGCAGAAGGAGATTACTG R: CTCAGGAGGAGCAATGATCTTGAT 72 bp 25
OCT4 F: GGAAGGAATTGGGAACACAAAGG R: AACTTCACCTTCCCTCCAACCA 71 bp 30
SOX2 F: GCTACAGCATGATGCAGGACCA R: TCTGCGAGCTGGTCATGGAGTT 135 bp 30
c-myc F: CCTGGTGCTCCATGAGGAGAC R: CAGACTCTGACCTTTTGCCAGG 128 bp 30
KLF4 F: CATCTCAAGGCACACCTGCGAA R: TCGGTCGCATTTTTGGCACTGG 156 bp 30
NANOG F: CCTGTGATTTGTGGGCCTG R: GACAGTCTCCGTGTGAGGCAT 78 bp 30
SEV F: GGATCACTAGGTGATATCGAGC R: ACCAGACAAGAGTTTAAGAGATATGTATC 181 bp 35
NESTIN F: GGAGAAGGACCAAGAACTG R: ACCTCCTCTGTGGCATTC 153 bp qRT-PCR
T-Brachyury F: CCTTCAGCAAAGTCAAGCTCACC R: TGAACTGGGTCTCAGGGAAGCA 153 bp qRT-PCR
FGF5 F: GGAATACGAGGAGTTTTCAGCAAC R: CTCCCTGAACTTGCAGTCATCTG 99 bp qRT-PCR
AFP F: GCAGAGGAGATGTGCTGGATTG R: CGTGGTCAGTTTGCAGCATTCTG 113 bp qRT-PCR
β3-TUBULIN F: TCAGCGTCTACTACAACGAGGC R: GCCTGAAGAGATGTCCAAAGGC 120 bp qRT-PCR
632 M. Marcatili et al. / Stem Cell Research 17 (2016) 630–633Interleukin-3 (IL-3) (Thermo Fisher Scientiﬁc). The medium was re-
placed daily for the following 3 days.
In order to deliver reprogramming genes in PBMCs, viral particles
provided with the CytoTune-iPS 2.0 Sendai Reprogramming Kit (Ther-
mo Fisher Scientiﬁc) were used following the manufacturer's protocol.
Three weeks post-transduction colonies with iPSCs morphology ap-
peared and were picked, transferred onto a new well and cultured on
Geltrex-coated plastic dish in E8 according to the manufacture's
protocol.
In vitro differentiation
Embryoid body (EB) formation assay was performed by gently
resuspending iPSCs clumps in 100-mm non-tissue culture-treated dish
in Essential 6 medium (E6 medium; Thermo Fisher Scientiﬁc). Medium
was changed daily. At day 7, EBs were collected and plated on Geltrex-
coated dishes in E6 medium to allow growth in adhesion for further
7 days. Medium was changed every other day.
RNA isolation, polymerase chain reaction (PCR) and quantitative-PCR
(qPCR)
RNAwas isolatedwith the TRIzol Reagent (Thermo Fisher Scientiﬁc)
following the manufacture's protocol and reverse transcribed using
iScript cDNA Synthesis Kit (BioRad). Transcripts of interest were ampli-
ﬁed using EURO TAQ Thermostable DNApolymerase (EUROCLONE) and
detection of genes of interestwas conﬁrmedwith speciﬁc primes (Table
1). Quantitative Reverse Transcription-Polymerase Chain Reaction
(qRT-PCR) was performed using the SsoAdvanced Universal SYBR
Green Supermix Kit following the manufacturer's instructions. Beta-Table 2
List of the antibodies used in for immunocytochemistry (IC) and Western Blot (WB) assays, w
Antibody Company
TRA 1-60 Santa Cruz Biotech
NANOG Santa Cruz Biotech
SOX2 Millipore
OCT4 (WB) Santa Cruz Biotech
LAMIN A/C Santa Cruz Biotech
OCT4 (IC) Santa Cruz Biotech
α-SMA Sigma
TROMA-1 Iowa DHB
AFP Abnova
β3-TUBULIN Promega
Anti-rabbit HRP BioRad
Anti-mouse HRP BioRad
Anti-mouse IgM FITC Santa Cruz Biotech
Alexa Fluor IgG anti-rabbit 568 Life Technologies
Alexa Fluor IgG anti-rabbit 488 Life Technologies
Anti-mouse IgM FITC Santa Cruz Biotech
Alexa Fluor IgG Anti-mouse 568 Life Technologiesactin was used as housekeeping gene to normalize data. Ampliﬁcation
was performed on a CFX96 BioRad RealTime PCR machine. Results
were analyzed with BioRad CFX Manager dedicated software.
Immunoﬂuorescence assay
Cells were ﬁxed with PFA 4% for 15 min RT, permeabilized with Tri-
ton 0.5% for 15 min RT and blocked with blocking solution (10% FBS in
PBS) for 1 h RT. Cultures were then incubated with speciﬁc primary an-
tibodies overnight at 4 °C (Table 2) and stained for 45 min at RT with
secondary antibody andHoechst 33,258 1 μg/ml (Thermo Fischer Scien-
tiﬁc). Images were detected with the microscope Leica DM IL Led Fluo
with Leica DFC450 C camera (Leica Microsystem).
Western blot assay
Cultures were lysated in SDS Sample Buffer (62.5 mM Tris-HCl
ph 6.8; 2% SDS; 10%Glycerol; 50mMDTT; Bromophenol Blue). Samples
were boiled at 95 °C for 5 min and loaded in the 8% polyacrylamide gel
and proteins blotted on a PVDFmembrane bymeans of Trans Blot Turbo
apparatus (BioRad). Primary antibodies (Table 2) were incubated over-
night at 4 °C in agitation and secondary antibody for 45min at RT. Signal
was detected with the ECL Clarity system (BioRad) in dark chamber
UVITECH Cambridge (Uvitech) and Uvitech software was used to ac-
quire and analyze the data.
Karyotyping
Cell cultures were treated with colcemid (Gibco KaryoMAX
Colcemid solution in PBS, Thermo Fischer Scientiﬁc) at a ﬁnalorking dilution and species in which they are produced.
Dilution Species
1:1000 (WB) 1:200 (IC) Mouse IgM
1:1000 Mouse
1:2000 (WB) 1:300 (IC) Rabbit
1:1000 Mouse
1:1000 Rabbit
1:100 Rabbit
1:100 Mouse
1:100 Mouse
1:50 Rabbit
1:1000 Mouse
1:3000 Goat
1:3000 Goat
1:200 Goat
1:300 Goat
1:300 Goat
1:200 Goat
1:400 Donkey
633M. Marcatili et al. / Stem Cell Research 17 (2016) 630–633concentration of 10 ng/ml for 16 h (overnight) at 37 °C andmetaphases
harvest was carried out according to standard protocols. Brieﬂy, PBS
washed cells were treated with hypotonic solution (0.075 M KCl for
15 min at RT) and ﬁxed in acetic acid/methanol (1:3 v/v). Air-dried
metaphase spreads slides were analyzed by QFQ banding following
standard procedures. Microscope observation was performed using a
Nikon Eclipse 90i (Nikon Instruments, Japan) equipped with the acqui-
sition and analysis Genikon software (Nikon Instruments S.p.a. Italy).Acknowledgements
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